Survodutide 10mg

$110.00

Survodutide (code name: BI 456906) is an investigational, next-generation subcutaneous peptide medication co-developed by Boehringer Ingelheim and Zealand Pharma. It is currently generating substantial excitement in clinical medicine for its unique ability to treat both obesity and metabolic dysfunction-associated steatohepatitis (MASH / fatty liver disease).

Category: